No takes yet. Share an insight, caveat, or question.
Randomized trial compares performance of Aβ PET metrics for amyloid detection in asymptomatic ADAD carriers, suggesting improved diagnostics.
Zhou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: